Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I/II clinical trialBo Zhang, Binlei Liu, Fuxiang Zhou et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 107